No Data
No Data
RBC Capital Maintains Avid Bioservices(CDMO.US) With Hold Rating, Maintains Target Price $12.5
RBC Capital Sticks to Its Hold Rating for Avid Bioservices (CDMO)
Havencrest Homecare Platform, Avid Health at Home, Announces Additional Acquisition in North Carolina
Press Release: Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand
Express News | Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Gho and Ampersand
Avid Bioservices Insider Sold Shares Worth $1,783,032, According to a Recent SEC Filing
Unlock the Full List